AU2023213894B2 - Blood glucose stabilizing methods and compositions - Google Patents

Blood glucose stabilizing methods and compositions Download PDF

Info

Publication number
AU2023213894B2
AU2023213894B2 AU2023213894A AU2023213894A AU2023213894B2 AU 2023213894 B2 AU2023213894 B2 AU 2023213894B2 AU 2023213894 A AU2023213894 A AU 2023213894A AU 2023213894 A AU2023213894 A AU 2023213894A AU 2023213894 B2 AU2023213894 B2 AU 2023213894B2
Authority
AU
Australia
Prior art keywords
grams
milligrams
pea
protease
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2023213894A
Other languages
English (en)
Other versions
AU2023213894A1 (en
Inventor
Wai Shun MAK
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Digestiva Inc
Original Assignee
Digestiva Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Digestiva Inc filed Critical Digestiva Inc
Publication of AU2023213894A1 publication Critical patent/AU2023213894A1/en
Application granted granted Critical
Publication of AU2023213894B2 publication Critical patent/AU2023213894B2/en
Priority to AU2025205298A priority Critical patent/AU2025205298A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21014—Microbial serine proteases (3.4.21.14)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
AU2023213894A 2022-01-26 2023-01-25 Blood glucose stabilizing methods and compositions Active AU2023213894B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2025205298A AU2025205298A1 (en) 2022-01-26 2025-07-09 Blood glucose stabilizing methods and compositions

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263303112P 2022-01-26 2022-01-26
US63/303,112 2022-01-26
PCT/US2023/061253 WO2023147350A1 (en) 2022-01-26 2023-01-25 Blood glucose stabilizing methods and compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2025205298A Division AU2025205298A1 (en) 2022-01-26 2025-07-09 Blood glucose stabilizing methods and compositions

Publications (2)

Publication Number Publication Date
AU2023213894A1 AU2023213894A1 (en) 2024-08-15
AU2023213894B2 true AU2023213894B2 (en) 2025-04-10

Family

ID=87472642

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2023213894A Active AU2023213894B2 (en) 2022-01-26 2023-01-25 Blood glucose stabilizing methods and compositions
AU2025205298A Pending AU2025205298A1 (en) 2022-01-26 2025-07-09 Blood glucose stabilizing methods and compositions

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2025205298A Pending AU2025205298A1 (en) 2022-01-26 2025-07-09 Blood glucose stabilizing methods and compositions

Country Status (8)

Country Link
US (4) US11821013B2 (https=)
EP (1) EP4469075A4 (https=)
JP (1) JP2025504049A (https=)
KR (1) KR20250008727A (https=)
AU (2) AU2023213894B2 (https=)
CA (1) CA3250056A1 (https=)
MX (1) MX2024009289A (https=)
WO (1) WO2023147350A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4469075A4 (en) 2022-01-26 2025-09-10 Digestiva Inc METHODS AND COMPOSITIONS FOR STABILIZING BLOOD GLUCOSE
EP4709834A1 (en) * 2023-05-11 2026-03-18 Digestiva, Inc. Wine dehazing methods and compositions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014037438A1 (en) * 2012-09-05 2014-03-13 Novozymes A/S Polypeptides having protease activity
WO2020087017A1 (en) * 2018-10-26 2020-04-30 The Regents Of The University Of California Use of proteolytic enzymes to enhance protein bioavailability

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097145A (en) 1962-03-30 1963-07-09 Takeda Chemical Industries Ltd Acid protease and the production thereof
JPH05244957A (ja) 1991-10-04 1993-09-24 Suntory Ltd シュードモナス属細菌由来ペプスタチン非感受性酸性プロテアーゼ遺伝子
US6302685B1 (en) 1997-09-16 2001-10-16 University Of Medicine And Dentistry Of New Jersey Human lysosomal protein and methods of its use
JP2002078489A (ja) 2000-09-04 2002-03-19 Daiwa Kasei Kk セリン残基が活性発現に関与する新規酸性プロテアーゼ
US20040142325A1 (en) 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
US7320788B2 (en) 2002-02-14 2008-01-22 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for Celiac Sprue
EP1685764A1 (en) 2005-01-27 2006-08-02 Globus Egg Sciences B.V. Anti-hypertensive functional food products
RU2446210C2 (ru) 2006-02-02 2012-03-27 ДСМ АйПи АССЕТС Б.В. Пищевой продукт, содержащий специфичную к пролину протеазу, способ его производства и его применение для расщепления токсичных или аллергенных пептидов глютена
CN101455368B (zh) 2008-12-29 2012-06-27 陕西天宝大豆食品技术研究所 杏仁肽营养品及其制备方法
WO2011125015A2 (en) 2010-04-05 2011-10-13 Bar-Ilan University Protease-activatable pore-forming polypeptides
US20130034530A1 (en) 2011-04-29 2013-02-07 David R. Fantz Dietary Supplement Cognitive Support System
CA2882502A1 (en) 2011-08-10 2013-02-14 University Of Washington Through Its Center For Commercialization Compositions and methods for treating celiac sprue disease
US20130156884A1 (en) 2011-12-19 2013-06-20 Triarco Industries Protease enzymes for increased protein digestion rate and absorption and methods of using the same
US10266815B2 (en) 2013-08-14 2019-04-23 University Of Washington Through Its Center For Commercialization Compositions and methods for treating celiac sprue disease
CN106191183B (zh) 2015-05-04 2019-11-29 浙江海正药业股份有限公司 西兰花蛋白肽的制备方法及其应用
BE1023038B1 (fr) 2015-06-12 2016-11-09 Proteifood Sa Produit alimentaire expanse sec a base de proteine et son procede de fabrication
CA3013383A1 (en) * 2016-02-25 2017-08-31 Dupont Nutrition Biosciences Aps Method for producing a protein hydrolysate employing an aspergillus fumigatus tripeptidyl peptidase
ES3039968T3 (en) * 2016-06-23 2025-10-28 Ew Nutrition Gmbh Feed composition comprising an acid protease
AU2017380106B2 (en) 2016-12-22 2024-05-09 Ew Nutrition Gmbh Stable protease variants
EP4469075A4 (en) 2022-01-26 2025-09-10 Digestiva Inc METHODS AND COMPOSITIONS FOR STABILIZING BLOOD GLUCOSE

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014037438A1 (en) * 2012-09-05 2014-03-13 Novozymes A/S Polypeptides having protease activity
WO2020087017A1 (en) * 2018-10-26 2020-04-30 The Regents Of The University Of California Use of proteolytic enzymes to enhance protein bioavailability

Also Published As

Publication number Publication date
MX2024009289A (es) 2025-01-09
US20240124864A1 (en) 2024-04-18
CN119136820A (zh) 2024-12-13
JP2025504049A (ja) 2025-02-06
US12516306B2 (en) 2026-01-06
WO2023147350A1 (en) 2023-08-03
AU2023213894A1 (en) 2024-08-15
EP4469075A4 (en) 2025-09-10
US11821013B2 (en) 2023-11-21
KR20250008727A (ko) 2025-01-15
US20240117333A1 (en) 2024-04-11
AU2025205298A1 (en) 2025-07-31
CA3250056A1 (en) 2023-08-03
US20260103698A1 (en) 2026-04-16
EP4469075A1 (en) 2024-12-04
US20230257729A1 (en) 2023-08-17

Similar Documents

Publication Publication Date Title
US20260103698A1 (en) Blood glucose stabilizing methods and compositions
Zielińska et al. Evaluation of ACE, α-glucosidase, and lipase inhibitory activities of peptides obtained by in vitro digestion of selected species of edible insects
Lin et al. Angiotensin-I-converting enzyme (ACE)-inhibitory and antihypertensive properties of squid skin gelatin hydrolysates
Jiang et al. Purification and a molecular docking study of α-glucosidase-inhibitory peptides from a soybean protein hydrolysate with ultrasonic pretreatment
del Mar Yust et al. Rapeseed protein hydrolysates: a source of HIV protease peptide inhibitors
Pan et al. Purification and characterisation of a novel angiotensin-I converting enzyme (ACE)-inhibitory peptide derived from the enzymatic hydrolysate of Enteromorpha clathrata protein
Devi et al. Amino acid digestibility of extruded chickpea and yellow pea protein is high and comparable in moderately stunted South Indian children with use of a dual stable isotope tracer method
EP2088157A1 (en) Collagen peptide composition and food or beverage containing the same
Pertiwi et al. In vitro gastrointestinal simulation of tempe prepared from koro kratok (Phaseolus lunatus L.) as an angiotensin-converting enzyme inhibitor
Xiang et al. Purification, identification and molecular mechanism of dipeptidyl peptidase IV inhibitory peptides from discarded shrimp (Penaeus vannamei) head
WO2005117933A1 (en) Use of protein hydrolysates for the manufacture of a medicament for prophylaxis and/or treatment of a dpp-iv mediated condition
Matheswaran et al. Anti-Hypertensive and Anti-Microbial Activity of Protein Hydrolysate Obtained from Seven Edible Insects.
Pratiwi et al. Angiotensin-converting enzyme inhibitor activity of peptides derived from Kacang goat skin collagen through thermolysin hydrolysis
Li et al. Grass carp (Ctenopharyngodon idella) stefin A: Systematic research on its cloning, expression, characterization and tissue distribution
CN119136820B (zh) 稳定血液葡萄糖的方法和组合物
US20230042729A1 (en) Peptide constructs and compositions
KR102420699B1 (ko) 강도다리 유래의 신규한 항균 펩티드 및 이의 용도
HK40121374A (zh) 稳定血液葡萄糖的方法和组合物
Mine et al. Biologically active food proteins and peptides in health: an overview
CN110317251B (zh) 降糖多肽及其制备方法和应用
Kodama Xaa-Pro dipeptidase (eukaryotes)
CA2839296A1 (en) Methods for increasing insulin sensitivity and treating diabetes
González-Félix et al. Optimum activity and partial characterization of chymotrypsin from the sciaenids Cynoscion othonopterus, Cynoscion parvipinnis, and Cynoscion xanthulus
Karnila et al. Utilization Of Alcalase Enzyme In The Production Of Malong Fish Protein Hydrolysate (Congresox Talabon) As An Α-Glucosidase Enzyme Inhibitor
Onuh Antihypertensive and Antioxidant Properties of Chicken Skin Protein Hydrolysates: In vitro, in vivo, and Metaboloics Studies

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)